Clinical Trial Update: Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating non-invasive inhaled nitric oxide to reduce bronchopulmonary dysplasia in premature newborns has completed and results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2017-05-23